A Glucose “Spike” Is Not Automatically a Sign of Poor Metabolic Health
Consumer CGM platforms often focus heavily on keeping glucose curves as flat as possible.
But human glucose physiology is not supposed to be perfectly flat.
When carbohydrates are digested, glucose enters the circulation. Insulin increases, tissues take up glucose, and glucose concentrations subsequently fall.
Healthy people therefore experience post-meal glucose excursions.
A multicenter study of 153 healthy people without diabetes found an average sensor glucose of approximately 98–99 mg/dL in most age groups.
Participants spent a median:
96% of the day between 70 and 140 mg/dL
approximately 30 minutes per day above 140 mg/dL
approximately 15 minutes per day below 70 mg/dL
despite being healthy and nondiabetic.
More recent data demonstrate even wider physiological variation.
In the Framingham Heart Study, 560 people classified as normoglycemic spent an average of about:
87% of the day between 70 and 140 mg/dL
12% of the day above 140 mg/dL
roughly 15 minutes per day above 180 mg/dL
despite not meeting conventional criteria for prediabetes or diabetes.
That does not mean large glucose excursions are irrelevant.
Higher average glucose and greater glycemic variability can correlate with poorer metabolic health.
But it does mean that:
“My glucose briefly went above 140 mg/dL after eating” is not equivalent to “this meal damaged my metabolism.”
There is currently no universally accepted CGM definition of ideal normoglycemia in people without diabetes.
Can CGM Feedback Actually Change Behavior?
This is arguably the strongest case for CGM use outside diabetes.
Seeing physiological feedback in real time can make an abstract concept concrete.
Instead of being told that walking after dinner may influence glucose, a person can observe the difference on their own glucose trace.
Some trials suggest that this feedback can help.
In a randomized trial involving 40 young adults with overweight or obesity but without diabetes, both groups received education about low-glycemic-index and low-glycemic-load diets.
Only the intervention group also received real-time CGM feedback.
After eight weeks, the CGM group showed greater improvements in several measures including body weight, body fat, fasting glucose, HbA1c, and blood lipids.
Another randomized dietary intervention published in 2025 used flash CGM data to personalize nutrition counseling in adults with obesity.
Participants receiving personalized feedback showed improvements in body weight, abdominal fat, dietary intake, and several metabolic measures relative to controls.
Small randomized studies in people with prediabetes have also found that adding visible CGM feedback to individualized nutrition therapy can improve glucose metrics and some dietary behaviors.
These studies are encouraging.
But they do not prove that simply buying a CGM and watching glucose numbers produces the same benefits.
The intervention often includes:
CGM + dietitian + education + goal setting + repeated counseling.
CGM may be helping people engage with an already effective lifestyle intervention rather than functioning as an independent treatment.
Who Is Most Likely to Benefit?
The strongest rationale is probably not in already healthy people with consistently normal metabolic markers.
It is in people occupying the space between obvious metabolic health and established diabetes.
Examples may include people with:
prediabetes
overweight or obesity
strong family history of type 2 diabetes
metabolic syndrome
impaired glucose tolerance
certain endocrine disorders
metabolic dysfunction-associated steatotic liver disease
high risk of medication-induced hyperglycemia
A 2025 review evaluating CGM in people at elevated risk of diabetes described promising results in several such populations.
But the authors still concluded that current evidence does not support global CGM implementation for everyone at increased diabetes risk.
Importantly, CGM should also not currently replace established diagnostic testing.
The ADA continues to recommend:
fasting plasma glucose
HbA1c
or a 75-g oral glucose tolerance test
for screening and diagnosis of prediabetes and type 2 diabetes.
Its 2026 Standards explicitly state that evidence remains insufficient to use CGM for that purpose.
So if a consumer CGM repeatedly displays unusual glucose values, the appropriate conclusion is not necessarily:
“The CGM diagnosed insulin resistance.”
It may instead be:
“This pattern may justify conventional clinical testing.”
More Metabolic Data Can Also Create More Anxiety
There is another side to continuous monitoring that receives much less attention.
Providing someone with hundreds of glucose measurements every day creates many opportunities to classify normal biological variation as abnormal.
This may encourage useful experimentation.
It can also encourage unnecessary restriction.
A 2025 mixed-methods study involving CGM users who were not using insulin found that most participants reported positive dietary or physical-activity changes.
But psychological responses varied considerably.
More than two-thirds reported fear of type 2 diabetes when seeing elevated glucose values, and some users experienced distress related to their glucose readings. Greater eating-disorder symptoms were also associated with certain forms of CGM-related distress.
The study was small and cross-sectional, so it cannot show that CGMs caused those psychological effects.
But the concern is plausible.
A person could begin avoiding nutritious foods such as:
fruit
beans
whole grains
or other carbohydrate-containing foods
simply because they produce a visible glucose rise.
That would confuse a short-term biomarker response with overall nutritional quality.
The expert community also does not yet completely agree on how abnormal CGM traces should be interpreted in people without diabetes.
A recent study asked 18 CGM experts to independently interpret potentially unusual glucose reports from individuals without diabetes. There was substantial variation in whether clinicians recommended follow-up—even when HbA1c and fasting glucose were normal.
If experts do not yet have standardized interpretation rules, consumers should be cautious about assigning medical meaning to every glucose excursion shown by an app.